This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simonsen, S. Articles by Kjekshus, J. K. Search for Related Content PubMed PubMed Citation Articles by Simonsen, S. Articles by Kjekshus, J. K.

Circulation, Vol 58, 484-491, Copyright © 1978 by American Heart Association

ARTICLES

The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man

S Simonsen and JK Kjekshus

The effect of myocardial uptake of free fatty acids (FFAu) on myocardial oxygen consumption (MVO2) in relation to increased heart rate and inotropic stimulation was determined in patients with coronary artery disease. Submaximal atrial pacing and isoproterenol stimulation increased MVO2 by 66% and 142%, respectively, at similar heart rates. Inhibition of lipolysis with beta-pyridyl carbinol almost abolished FFAu and reduced MVO2 significantly. Increased heart rate contributed 47% and FFAu 50% of the raised MVO2 attributed to inotropic stimulation was 30%. Augmentation of FFAu by triglyceride/heparin infusion increased MVO2 significantly above control levels, both during pacing and isoproterenol infusion. We conclude that MVO2 is closely correlated to FFAu, catecholamines sensitize the heart to FFA, and increased FFAu account for a major part of the increased MVO2 during catecholamine stimulation. The importance of reducing heart rate and lipolysis to reduce myocardial oxygen requirements is emphasized.

This article has been cited by other articles:

				K. Mai, J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, S. Meinus, F. Reinecke, M. Mohlig, M. O. Weickert, et al. Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21 Diabetes, July 1, 2009; 58(7): 1532 - 1538. [Abstract] [Full Text] [PDF]

				M. Harvey, G. Cave, and A. Kazemi Intralipid Infusion Diminishes Return of Spontaneous Circulation After Hypoxic Cardiac Arrest in Rabbits Anesth. Analg., April 1, 2009; 108(4): 1163 - 1168. [Abstract] [Full Text] [PDF]

				B. C. Bergman, T. Tsvetkova, B. Lowes, and E. E. Wolfel Myocardial FFA metabolism during rest and atrial pacing in humans Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E358 - E366. [Abstract] [Full Text] [PDF]

				D. J. Chess and W. C. Stanley Role of diet and fuel overabundance in the development and progression of heart failure Cardiovasc Res, July 15, 2008; 79(2): 269 - 278. [Abstract] [Full Text] [PDF]

				L. Zhou, H. Huang, C. L. Yuan, W. Keung, G. D. Lopaschuk, and W. C. Stanley Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H954 - H960. [Abstract] [Full Text] [PDF]

				D. Neglia, A. De Caterina, P. Marraccini, A. Natali, M. Ciardetti, C. Vecoli, A. Gastaldelli, D. Ciociaro, P. Pellegrini, R. Testa, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3270 - H3278. [Abstract] [Full Text] [PDF]

				D. J. Durgan, M. W. S. Moore, N. P. Ha, O. Egbejimi, A. Fields, U. Mbawuike, A. Egbejimi, C. A. Shaw, M. S. Bray, V. Nannegari, et al. Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2385 - H2393. [Abstract] [Full Text] [PDF]

				J. Chang, J. E. Cornell, H. Van Remmen, K. Hakala, W. F. Ward, and A. Richardson Effect of Aging and Caloric Restriction on the Mitochondrial Proteome J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 223 - 234. [Abstract] [Full Text] [PDF]

				D. J. Durgan, J. K. Smith, M. A. Hotze, O. Egbejimi, K. D. Cuthbert, V. G. Zaha, J. R. B. Dyck, E. D. Abel, and M. E. Young Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2480 - H2497. [Abstract] [Full Text] [PDF]

				J. D. Schipke, R. Friebe, and E. Gams Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 479 - 485. [Abstract] [Full Text] [PDF]

				W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]

				W. C. Stanley Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S31 - S45. [Abstract] [PDF]

				P. F. Soto, P. Herrero, A. M. Kates, C. S. Dence, A. A. Ehsani, V. Davila-Roman, K. B. Schechtman, and R. J. Gropler Impact of aging on myocardial metabolic response to dobutamine Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2158 - H2164. [Abstract] [Full Text] [PDF]

				H. Fraser, Z. Gao, M. J. Ozeck, and L. Belardinelli N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1 Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 225 - 231. [Abstract] [Full Text]

				T. Ramanathan, K. Shirota, S. Morita, T. Nishimura, Y. Huang, X. Zheng, and S. Hunyor Left ventricular oxygen utilization efficiency is impaired in chronic streptozotocin-diabetic sheep Cardiovasc Res, September 1, 2002; 55(4): 749 - 756. [Abstract] [Full Text] [PDF]

				M. P. Chandler, W. C. Stanley, H. Morita, G. Suzuki, B. A. Roth, B. Blackburn, A. Wolff, and H. N. Sabbah Short-Term Treatment With Ranolazine Improves Mechanical Efficiency in Dogs With Chronic Heart Failure Circ. Res., August 23, 2002; 91(4): 278 - 280. [Abstract] [Full Text] [PDF]

				H. N. Sabbaha and W. C. Stanley Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure Eur J Heart Fail, January 1, 2002; 4(1): 3 - 6. [Full Text] [PDF]

				F. A. Recchia, J. C. Osorio, M. P. Chandler, X. Xu, A. R. Panchal, G. D. Lopaschuk, T. H. Hintze, and W. C. Stanley Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E197 - E206. [Abstract] [Full Text] [PDF]

				C. Korvald, O. P. Elvenes, and T. Myrmel Myocardial substrate metabolism influences left ventricular energetics in vivo Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1345 - H1351. [Abstract] [Full Text] [PDF]

				E. J. Eichhorn and M. R. Bristow Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure Circulation, November 1, 1996; 94(9): 2285 - 2296. [Abstract] [Full Text]

				D. Ornish, L. W. Scherwitz, R. S. Doody, D. Kesten, S. M. McLanahan, S. E. Brown, E. G. DePuey, R. Sonnemaker, C. Haynes, J. Lester, et al. Effects of Stress Management Training and Dietary Changes in Treating Ischemic Heart Disease JAMA, January 7, 1983; 249(1): 54 - 59. [Abstract] [PDF]